Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRights &iss. Regulatory News (RIII)

Share Price Information for Rights &iss. (RIII)

Share Price is delayed by 15 minutes
Get Live Data
2,200.00    10.00 (0.46%)
Bid:
2,160.00
Ask:
2,200.00
Spread: 40.00 (1.852%)
Market Cap: £103.56m
RIII Live PriceLast checked at - London Stock Exchange

Intraday Rights &iss. Share Chart

2024 AGM Voting Results Update Statement

21 Jun 2024 07:00

RNS Number : 3240T
Rights and Issues Inv. Trust PLC
21 June 2024
 

Rights and Issues Investment Trust plc

(the "Company")

 

LEI: 2138002AWAM93Z6BP574

 

2024 AGM Voting Results Update Statement

In accordance with Provision 4 of the UK Corporate Governance Code, the Company today provides an update in respect of the results of its Annual General Meeting (AGM) held on 27 March 2024, where resolution 2 (to approve the Directors' Remuneration Report) and resolution 5 (to re-elect Mr Simon Knott as a Director) were passed with the necessary majority but with more than 20% of votes cast against the resolutions by shareholders.

The Board has liaised with the significant shareholder who voted against both resolutions and understands that the reasons for the vote against the Directors' Remuneration Policy was because of the ex-gratia payment to Dr David Bramwell, the former Chairman. This payment was to fund a gift in recognition of Dr Bramwell's long service to the Company and his contribution as Chair. The shareholder acknowledged that the sum of the payment was insignificant and the Board confirms that this payment was not intended to set a precedent for any such payments in the future and does not envisage making such a payment again.

Regarding the decision to vote against the re-election of Mr Simon Knott, the Board understands that the shareholder's reasons related to their view that Mr Knott was non-independent, having formerly been the CEO of the Company prior to the appointment of Jupiter Unit Trust Managers Limited ('JUTM') as investment manager in October 2022, when it was a self-managed investment trust. The Board has clarified with the shareholder that Mr Knott has no current or former association with JUTM other than as a non-executive director of the Company and, despite his tenure as Investment Director, the Board considers him to be independent. With his extensive investment knowledge and in-depth understanding of the companies within the portfolio, Mr Knott's contribution to the Board and its committees is invaluable.

 

Contacts:

The Board (via Apex Group)

cosec-uk@apexgroup.com

 

Cavendish Capital Markets Limited

Tunga Chigovanyika

tchigovanyika@cavendish.com

 

Jupiter Asset Management

Nick Black

investmentcompanies@jupiteram.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFBMBTMTBTMII
Date   Source Headline
28th Mar 20252:50 pmRNSNet Asset Value(s)
27th Mar 202512:55 pmRNSNet Asset Value(s)
26th Mar 202510:16 amRNSNet Asset Value(s)
25th Mar 202510:20 amRNSNet Asset Value(s)
25th Mar 20257:01 amRNSSuspension of Share Repurchase Programme
25th Mar 20257:00 amRNSResult of AGM
24th Mar 202512:22 pmRNSNet Asset Value(s)
21st Mar 20255:14 pmRNSTransaction in Own Shares
21st Mar 202512:12 pmRNSNet Asset Value(s)
20th Mar 20252:26 pmRNSNet Asset Value(s)
19th Mar 202510:14 amRNSNet Asset Value(s)
18th Mar 202511:38 amRNSNet Asset Value(s)
17th Mar 202510:32 amRNSNet Asset Value(s)
14th Mar 202510:13 amRNSNet Asset Value(s)
13th Mar 202510:37 amRNSNet Asset Value(s)
12th Mar 202511:21 amRNSNet Asset Value(s)
11th Mar 202512:13 pmRNSNet Asset Value(s)
10th Mar 20252:15 pmRNSNet Asset Value(s)
7th Mar 20255:59 pmRNSTransaction in Own Shares
7th Mar 20253:51 pmRNSDirector/PDMR Shareholding
7th Mar 202512:55 pmRNSNet Asset Value(s)
6th Mar 202511:29 amRNSNet Asset Value(s)
5th Mar 20252:03 pmRNSNet Asset Value(s)
4th Mar 202510:13 amRNSNet Asset Value(s)
3rd Mar 202511:00 amRNSNet Asset Value(s)
3rd Mar 202510:58 amRNSTotal Voting Rights
28th Feb 20255:17 pmRNSNet Asset Value(s)
28th Feb 202510:22 amRNSNet Asset Value(s)
27th Feb 20251:13 pmRNSNet Asset Value(s)
26th Feb 202510:45 amRNSNet Asset Value(s)
25th Feb 202512:36 pmRNSNet Asset Value(s)
24th Feb 20253:14 pmRNSNet Asset Value(s)
21st Feb 202512:09 pmRNSNet Asset Value(s)
21st Feb 20257:02 amRNSDividend Declaration
21st Feb 20257:00 amRNSFinal Results
20th Feb 202510:46 amRNSNet Asset Value(s)
19th Feb 202510:07 amRNSNet Asset Value(s)
18th Feb 202510:12 amRNSNet Asset Value(s)
17th Feb 20255:04 pmRNSTransaction in Own Shares
17th Feb 202510:26 amRNSNet Asset Value(s)
14th Feb 202511:47 amRNSNet Asset Value(s)
13th Feb 202512:58 pmRNSNet Asset Value(s)
12th Feb 202511:58 amRNSNet Asset Value(s)
11th Feb 202512:08 pmRNSNet Asset Value(s)
10th Feb 202510:43 amRNSNet Asset Value(s)
7th Feb 20255:22 pmRNSTransaction in Own Shares
7th Feb 202511:58 amRNSNet Asset Value(s)
6th Feb 20253:40 pmRNS-RUpdate note from QuotedData
6th Feb 20259:56 amRNSNet Asset Value(s)
5th Feb 202511:03 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.